Abstract
Addictive drugs are primarily made up of herbal substances and are certainly older than humanity. Addictive drugs are pharmacological effective substances and therefore comply with the accepted pharmacological rules. They have been applied by mankind for thousands of years, and a range of diseases were treated with addictive drugs. It has been known for more than 2000 years that viruses can be driven away by using smoke (fire or tobacco smoke) and alcohol. About 150 years ago, contaminated water in Europe caused severe bodily discomfort (even with lethal consequences). Yet, these adverse health effects were in no case observable when alcohol was consumed in low amounts. Alcohol is still used as a disinfectant agent, and even today, Shamans of the Upper Amazonas still use alcohol and smoke to blow off viruses. The psychopharmacological effects of alcohol have always been known, and virtually in every culture, there were distinct rules stating in which doses, at what time and at which occasions alcohol and tobacco were allowed to be consumed and even enjoyed (Indian rituals [e.g. calumet] or mandatory carousals in the Mexican culture). If these rituals were not obeyed, then alcohol and tobacco consumption was in fact always connected with severe punishment, which could even range to the point of death sentence.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ait-Daoud N, Wiesbeck GA, Bienkowski P, Li MD, Pfützer RH, Singer MV, Lesch OM, Johnson BA. Comorbid alcohol and nicotine dependence: from the biomolecular basis to clinical consequences. Alcohol Clin Exp Res. 2005;29(8):1541–9.
Castaldelli-Maia JM, Martins SS, Storr CL, Viana MC, Andrade LH, Andreade AG. Investigating the dimensional diagnosis of ICD-11 nicotine dependence. Psychol Addict Behav. 2018;32(4):415–25.
Hertling I, Ramskogler K, Dvorak A, Klingler A, Saletu-Zyhlarz G, Schoberberger R, Walter H, Kunze M, Lesch OM. Craving and other characteristics of the comorbidity of alcohol and nicotine dependence. Eur Psychiatry. 2005;20(5–6):442–50.
Hester RK, Miller WR. Handbook of alcoholism and treatment approaches. Effective alternatives. 3rd ed: Allyn & Bacon; 2003.
Johnson BA, Ruiz P, Galanter M. Handbook of clinical alcoholism treatment: Lippincott Williams & Wilkins; 2003.
Lesch OM. Addiction in DSM V and ICD-11 state of the art. Fortschr Neurol Psychiatr. 2009;77(9):507–12.
Lesch OM, Dvorak A, Hertling I, Klingler A, Kunze M, Ramskogler K, Saletu-Zylharz G, Schoberberger R, Walter H. The Austrian multicentre study on smoking: subgroups of nicotine dependence and their craving. Neuropsychobiology. 2004;50:78–88.
Miller WR, Rollnick S. Motivational interviewing: preparing people for change. 2nd ed. New York: Guilford Press; 2002.
Paulino S, Pombo S, Ismail F, Figueira ML, Lesch O. The role of effective temperament as a predictor of relapse alcohol dependence. Personal Ment Health. 2017;11(4):278–89.
Platz W. Forensische psychiatrie. In: Brüssow R, Gatzweiler N, Krekeler W, Mehle V, editors. Strafverteidigung in der Praxis. 4th ed: Deutscher Anwalt Verlag; 2007.
Plinius Secundus G. Naturalis Historiae, Tomus Prinus. 1669
Pombo S, Reizinho R, Ismail F, Barbosa A, Figueira LM, Cardoso JMN, Lesch OM. NETER1 alcoholic 5 subtypes: validity with Lesch four evolutionary subtypes. Int J Psychiatry Clin Pract. 2008;12(1):55–64.
Poznyak V, Reed GM, Medina-Mora ME. Aligning the ICD-11 classification of disorders due to substance use with global service needs. Epidemiol Psychiatry Sci. 2018;27(3):212–8.
Prochaska J, DiClemente C. Stages of change in modification of problem behaviors. In: Hersen M, Eisler R, Miller P, editors. Progress in behavior modification. Newbury Park, CA: Sage; 1992. p. 84–218.
Rommelspacher H, Schuckit M. Drugs of abuse: Elsevier; 1996.
Saunders JB. Substance us e and addictive disorders in DSM-5 and ICD-10 and the draft ICD-11. Curr Opin Psychiatry. 2017;30(4):227–37.
Schmidt G, Sucht-„Krankheit“ und/oder Such(t) – Kompetenzen lösungsorientierte systemische Therapiekonzepte für eine gleichrangig-partnerschaftliche Umgestaltung von „Sucht“ in Beziehungs- und Lebensressourcen. In: Richelshagen K. Süchte und Systeme. Lambertus-Verlag 1992.
Sinclair JD. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol. 2001;36(1):2–10.
Siqueira LM, Committee on Substance Use and Prevention. Nicotine and tobacco as substances of abuse in children and adolescents. Pediatrics. 2017;139(1):e20163436.
Trova AC, Paparrigopoulos T, Liappas I, Ginieri-Coccossis M. Prevention of alcohol dependence. Psychiatike. 2015;26(2):131–40.
Volpicelli JR, Pettinati HM, McLellan AT, O’Brien CP. Combining medication and psychosocial treatments for addictions: the BRENDA method. New York, NY: Guilford Press; 2001.
Widiger TA, Samith GT. Substance usae disorder: abuse, dependence and dyscontrol. Addiction. 1994;89(3):267–82.
Wieck HH. Lehrbuch für Psychiatrie. Stuttgart: Schattauer; 1967.
Yeh TC, Wang SC, Chang YT, Yeh CB. Predictors of nicotine dependence in adolescents: symptoms of bipolar disorder and attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2017;27(4):366–73.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lesch, OM., Walter, H., Wetschka, C., Hesselbrock, M.N., Hesselbrock, V., Pombo, S. (2020). Addiction: A Short Overview of a Widespread Disease. In: Alcohol and Tobacco. Springer, Cham. https://doi.org/10.1007/978-3-030-41941-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-41941-7_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-41940-0
Online ISBN: 978-3-030-41941-7
eBook Packages: MedicineMedicine (R0)